Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1191 participants.
Also called NCT01556126
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,191 participants
- Sponsor
- CID - Carbostent & Implantable Devices
- Registry
-
NCT01556126
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Belgium, Italy, Netherlands, Norway, Poland
- Registry status
- Completed
Technical summary
Registry record NCT01556126. Allocation not applicable; no masking; primary purpose treatment. Start 2012-02 (actual); primary completion 2014-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
- Acronym
- PARTICIPATE
- Condition
- Stable Angina
- Condition
- Unstable Angina
- Condition
- Acute Myocardial Infarction
- Intervention (Device)
- Amphilimus Eluting Stent (CRE8)
- Lead sponsor
- CID - Carbostent & Implantable Devices
Record details
- Record id
cardio:ct-nct01556126- Content hash
77804d872f2c14a53ad478bba095837792cd96427320ba38db1523b4e1c7e6af